Vietnam Minister of Planning and Investment visits AstraZeneca China

April 01, 2024 | 15:02
(0) user say
A Vietnamese delegation led by Minister for Planning and Investment Nguyen Chi Dung on March 30 visited AstraZeneca Global (R&D) China Centre and the Shanghai Jing'an CCiC & iCampus.

Welcoming the minister was Nitin Kapoor, vice president of Biopharmaceuticals International and chairman of AstraZeneca Vietnam, together with Nicholas Cong, head of International Commercial Operations and Chandler Chen, executive director of the iCampus and Regional Innovation Centre.

Vietnam Minister of Planning and Investment visits AstraZeneca China

Along with the visit to AstraZeneca Global (R&D) China Centre, laboratories and facilities, Minister Dung also held discussions with AstraZeneca leaders on promoting innovation and scientific collaboration, facilitating research, experience exchange, and attracting resources to leverage innovation, and attracting investment in high-tech, innovative healthcare projects.

He also expressed his high expectation that with the support from AstraZeneca and its partners, Vietnam could improve the operational efficiency of its innovation model in science, technology, and AI, particularly within healthcare.

“The application of science, technology, and innovation across all sectors is a sustainable and effective pathway for Vietnam's development. Healthcare innovation plays a crucial role in disease prevention, detection, and diagnosis. The scale and modernity of AstraZeneca's global research and development (R&D) centre and the wider innovation ecosystem it fosters serve as a prime example of successful investment cooperation between businesses and the state, which offers valuable learnings and can be referenced for Vietnam's innovation centre (NIC)," the MPI minister said.

Vietnam Minister of Planning and Investment visits AstraZeneca China

Nitin Kapoor said, "For the past 30 years, AstraZeneca has been a trusted partner in Vietnam's healthcare development, striving to improve healthcare capacity and community health. Looking ahead, we commit to continued investment and knowledge sharing in digital applications, AI, and promoting healthcare transformation to enhance screening efficiency and early disease detection. This will ultimately reduce the burden on patients, families, and society.”

In late 2023, together with the Vietnamese Young Physicians' Association, AstraZeneca launched the "Healthcare Innovation Network," and the first phase focused on the "Digital Transformation for Lung Health" project, which helped over 100,000 people. It serves as a significant leap towards innovation in healthcare and digital/AI transformation.

Through collaboration with AstraZeneca, China has established a collaborative healthcare innovation ecosystem, this high-tech platform integrates various resources, fostering the incubation of innovative healthcare models and the development of new biological treatments alongside diagnostic and monitoring equipment for smart healthcare.

Vietnam Minister of Planning and Investment visits AstraZeneca China

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism; respiratory and immunology, gastroenterology; vaccines and immune therapies. Based in Cambridge, the United Kingdom, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

As a foreign invested enterprise with over 600 employees, AstraZeneca Vietnam is investing $360 million from 2020 to 2030 into the country with a focus on reducing the burdens of diseases, uplifting the domestic biopharmaceutical R&D and manufacturing capabilities, and developing local talent.

Moreover, in May 2023, the company announced a new investment of up to $50 million in Vietnam, as part of the its global AZ Forest programme to restore Vietnam’s forests and landscapes, support the Vietnamese government’s 2050 net-zero strategy.

AstraZeneca Vietnam chairman awarded Friendship Medal AstraZeneca Vietnam chairman awarded Friendship Medal

Nitin Kapoor, chairman and general director of AstraZeneca Vietnam, has been bestowed with the Friendship Medal by State President in recognition of his extraordinary leadership during the pandemic and in his relentless pursuit of ongoing healthcare improvements.

AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam AstraZeneca, VYPA sign MOU to enhance healthcare in Vietnam

AstraZeneca Vietnam and the Vietnam Young Physicians Association (VYPA) on January 28 signed a MoU to elevate cooperation between the two organisations to new heights.

AstraZeneca Vietnam dedicated to health AstraZeneca Vietnam dedicated to health

AstraZeneca Vietnam has started the year by building on last year’s success with programmes that cater to improving livelihoods and enhancing healthcare.

By Bich Thuy

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional